BioSpace News Archive

Drug Development

KAHR and Cancer Focus Fund Announce First Patient Dosed in Phase 1b Clinical Trial of Anti-CD47 Product Candidate DSP107 in Blood Cancers

KAHR, today announced that the first patient has been dosed in a Phase 1b clinical trial of DSP107.

February 17, 2022

·

5 min read

Business

Lyra Therapeutics Appoints Harlan W. Waksal, MD, as Executive Chairman

Lyra Therapeutics today announced the appointment of Harlan W. Waksal MD, as Executive Chairman.

February 17, 2022

·

7 min read

Drug Development

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Supplemental Biologics License Application for Breyanzi

U.S. Food and Drug Administration (FDA) Accepts for Priority Review Bristol Myers Squibb’s Supplemental Biologics License Application for Breyanzi (lisocabtagene maraleucel) as a Second-Line Therapy for Relapsed or Refractory Large B-cell Lymphoma.

February 17, 2022

·

17 min read

Drug Development

Modra Pharmaceuticals Presents Positive Phase IIb Results for ModraDoc006/r, a Boosted Oral Taxane for Patients with Metastatic Prostate Cancer, at 2022 ASCO GU Annual Meeting

Modra Pharmaceuticals announced positive data from its Phase IIb trial evaluating its boosted oral taxane therapeutic, ModraDoc006/r, in patients with metastatic Castration-Resistant Prostate Cancer compared to the standard-of-care, the IV chemotherapy docetaxel.

February 17, 2022

·

5 min read

Immunovia Publishes Full Year Report 2021

Immunovia has published its full year report 2021.

February 17, 2022

·

11 min read

MediWound Awarded a U.S. Department of Defense Research Grant for the Development of NexoBrid for the U.S. Army

MediWound Ltd. announced that the U.S. Department of Defense, through the Medical Technology Enterprise Consortium, has awarded MediWound a $1.7 million research project for the development of NexoBrid® as a non-surgical solution for field-care burn treatment for the U.S. Army.

February 17, 2022

·

8 min read

Business

West Announces Fourth-Quarter and Full-Year 2021 Results

West Pharmaceutical Services, Inc. announced its financial results for the fourth-quarter and full-year 2021 and introduced full-year 2022 financial guidance.

February 17, 2022

·

15 min read

Business

Neumora Expands Precision Neuroscience Pipeline with Novel M4 Receptor Modulator Program Through Exclusive License Agreement with Vanderbilt University

Neumora to develop and commercialize M4-selective muscarinic receptor positive allosteric modulator program for schizophrenia and other neuropsychiatric disorders.

February 17, 2022

·

4 min read

Biotech Bay

Aridis’ Pan-Coronavirus Monoclonal Antibody Cocktail AR-701 Is Protective in COVID-19 Omicron Infected Animals

Aridis Pharmaceuticals, Inc., a biopharmaceutical company focused on the discovery and development of novel anti-infective therapies to treat life-threatening infections, announced that both of its fully human monoclonal antibodies in the AR-701 cocktail neutralized the SARS-CoV-2 Omicron variant.

February 17, 2022

·

8 min read

Business

Seegene Announces Q4 and Full-Year 2021 Financial Results

Seegene Inc. today announced full-year 2021 financial results that marked an all-time high record with total sales increasing 22% year-over-year (YoY) to KRW 1.37 trillion (approx. US$1.14 billion).

February 17, 2022

·

4 min read